Establishment of a novel obesity mouse model: the induction of intestinal microbiota dysbiosis

Qiuju Li,Xiaolin Gao,Ruizhen Jia,Jianjun Deng,Chaomin Wan
DOI: https://doi.org/10.1038/s41598-024-63964-2
IF: 4.6
2024-06-13
Scientific Reports
Abstract:To establish and evaluate an intestinal microbiota dysbiosis-induced obesity mouse model. 50 C57BL/6 J male healthy mice were randomly divided into an obesity model group and the control group. The body weight, body length, and Lee's index of the two groups of mice at week 1 and week 10 were compared. Serum glucose (GLU), total cholesterol (TC) and triglyceride (TG) were measured by enzyme-labeled colorimetric methods. Illumina HiSeq 16S rDNA high-throughput sequencing technology was used to characterize intestinal microbiota in feces. The success rate of model establishment in obese mice was 52%. The body weight, body length, Lee's index, and abdominal fat (wet weight) in the obese model group were all higher than those in the control group, and the differences were statistically significant ( P < 0.01). Serum GLU and TC levels in the obesity model group were higher than those in the control group ( P < 0.05), and there was no difference in TG levels between the two groups ( P > 0.05). The control group contained more abundant intestinal microbiota phyla and genera than did the obesity model group; the differences between the two groups were significant ( FDR ≤ 0.05, P ≤ 0.05). Intestinal microbiota dysbiosis can be used to generate an obesity model in mice.
multidisciplinary sciences
What problem does this paper attempt to address?
The problem this paper attempts to address is the establishment of an obesity mouse model induced by gut microbiota dysbiosis and the evaluation of its effectiveness and stability. Specifically, the researchers aim to simulate obesity by using antibiotics to induce gut microbiota dysbiosis and to verify the feasibility of this model by comparing physiological indicators, serum biochemical indicators, and gut microbiota characteristics between the model group and the control group of mice. ### Main Research Content: 1. **Experimental Design**: - Select 50 healthy male C57BL/6J mice and randomly divide them into an obesity model group and a control group, with 25 mice in each group. - The model group mice were given a combination of four antibiotics (ampicillin, neomycin, metronidazole, and vancomycin) via gavage for 7 consecutive days, followed by continuous addition of these antibiotics in their drinking water. - The control group mice were given an equal amount of sterile water daily. 2. **Measurement Indicators**: - Measure the body weight, body length, and Lee index of the mice in the 1st week and the 10th week. - Determine the levels of serum glucose (GLU), total cholesterol (TC), and triglycerides (TG). - Analyze the gut microbiota in feces using Illumina HiSeq 16S rDNA high-throughput sequencing technology. 3. **Results**: - The body weight, body length, Lee index, and wet weight of abdominal fat in the model group mice were significantly higher than those in the control group (P < 0.01). - The serum GLU and TC levels in the model group mice were significantly higher than those in the control group (P < 0.05), while the TG levels showed no significant difference (P > 0.05). - The gut microbiota diversity in the model group mice was significantly lower than that in the control group, with significant differences at the phylum and genus levels. ### Conclusion: By using antibiotics to induce gut microbiota dysbiosis, an obesity mouse model was successfully established. Although the modeling time is relatively long and the success rate is low (about 52%), this model is simple and feasible, with controllable conditions. It can serve as a basic model for studying obesity induced by gut microbiota dysbiosis. This provides a reference for further exploration of the mechanisms, diagnosis, and treatment of obesity.